标题
A Review on Dengue Vaccine Development
作者
关键词
-
出版物
Vaccines
Volume 8, Issue 1, Pages 63
出版商
MDPI AG
发表日期
2020-02-04
DOI
10.3390/vaccines8010063
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of the oral immunogenicity of M cell-targeted tetravalent EDIII antigen for development of plant-based edible vaccine against dengue infection
- (2019) Byeong-Young Kim et al. PLANT CELL TISSUE AND ORGAN CULTURE
- Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
- (2018) Janine R. Danko et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
- (2018) Jyotiranjan Bal et al. Microbial Cell Factories
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
- (2018) Rahul Shukla et al. Frontiers in Microbiology
- Dengue vaccine: reliably determining previous exposure
- (2018) Kevin K Ariën et al. Lancet Global Health
- Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children
- (2018) Sriluck Simasathien et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Recent Developments in Recombinant Protein–Based Dengue Vaccines
- (2018) Nagesh K. Tripathi et al. Frontiers in Immunology
- A recombinant live attenuated tetravalent vaccine for the prevention of dengue
- (2017) Bruno Guy et al. Expert Review of Vaccines
- Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate
- (2017) Mi-Young Kim et al. PLANT BIOTECHNOLOGY JOURNAL
- Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence
- (2017) Jin Sun et al. VACCINE
- Towards development of a universal dengue vaccine – How close are we?
- (2017) Ee Leen Pang et al. Asian Pacific Journal of Tropical Medicine
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
- (2016) Chen-Yi Chiang et al. VACCINE
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
- (2016) Chen-Yi Chiang et al. Scientific Reports
- Vaccines and immunization strategies for dengue prevention
- (2016) Yang Liu et al. Emerging Microbes & Infections
- Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
- (2015) Huabin Liang et al. Cellular & Molecular Immunology
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
- (2015) Naphak Modhiran et al. Science Translational Medicine
- Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
- (2015) Ilaria Dorigatti et al. VACCINE
- Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
- (2015) Dhanasekaran Govindarajan et al. VACCINE
- Mouse models of dengue virus infection for vaccine testing
- (2015) Vanessa V. Sarathy et al. VACCINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus
- (2014) Laura Lazo et al. MICROBIOLOGY AND IMMUNOLOGY
- Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
- (2014) Hui Zhao et al. PLoS One
- Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
- (2014) Chen-Yi Chiang et al. VACCINE
- A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model
- (2014) Syed Muaz Khalil et al. VACCINE
- Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development
- (2014) Carlos A. Sariol et al. Frontiers in Immunology
- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
- (2013) Hsin-Wei Chen et al. ARCHIVES OF VIROLOGY
- Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells
- (2013) Aleš Berlec et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
- (2013) N. G. Reich et al. Journal of the Royal Society Interface
- An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
- (2013) L. J. White et al. JOURNAL OF VIROLOGY
- Correction: An Explosive Epidemic of DENV-3 in Cairns, Australia
- (2013) Scott A. Ritchie et al. PLoS One
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies
- (2012) Ryan S.L. Wu et al. ANTIVIRAL RESEARCH
- Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
- (2012) Jie Yang et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Using recombinant DNA technology for the development of live-attenuated dengue vaccines
- (2012) Hsiang-Chi Lee et al. ENZYME AND MICROBIAL TECHNOLOGY
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Development of dengue DNA vaccines
- (2011) Janine R. Danko et al. VACCINE
- Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
- (2011) Anna P. Durbin et al. VACCINE
- Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
- (2011) Joseph N. Brewoo et al. VACCINE
- Review of dengue virus and the development of a vaccine
- (2010) Sarah Murrell et al. BIOTECHNOLOGY ADVANCES
- Expression of dengue virus E glycoprotein domain III in non-nicotine transgenic tobacco plants
- (2010) Mi-Young Kim et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
- (2009) Saima Khanam et al. VACCINE
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
- (2009) W.W. Shanaka I. Rodrigo et al. VIROLOGY
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Mouse models of dengue virus infection and disease
- (2008) L YAUCH et al. ANTIVIRAL RESEARCH
- Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
- (2008) Laura Lazo et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
- (2008) J. Pradeep Babu et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started